Assignee
JUVENTAS CELL THERAPY LTD
CN·3 granted patents·2 pending applications·1 citations·filing 2021–2022
Top patents by PatentIndex Score
5 records- 0186US11547728B2CD19-targeted chimeric antigen receptor and use thereofJUVENTAS CELL THERAPY LTD·Filed 2021·Granted Jan 10, 2023·1 cites·8 claims
- 0274US12441779B2Plasmid combination and application thereof in preparing modified immune cellsJUVENTAS CELL THERAPY LTD·Filed 2022·Granted Oct 14, 2025·0 cites·14 claims
- 0374US2023201261A1Cd19-targeted chimeric antigen receptor and use thereofJUVENTAS CELL THERAPY LTD·Filed 2022·Application pending·0 cites
- 0469US11497771B2Plasmid combination and application thereof in preparing modified immune cellsJUVENTAS CELL THERAPY LTD·Filed 2021·Granted Nov 15, 2022·0 cites·17 claims
- 0552US2024191190A1Perfusion culture method for car-t cellsJUVENTAS CELL THERAPY LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JUVENTAS CELL THERAPY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →